Source link : https://www.mondialnews.com/2026/03/20/ozempic-is-about-to-go-generic-soon-in-india-china-and-canada/
Ozempic, the widely prescribed medication for type 2 diabetes and weight management, is set to go generic in key international markets including India, China, and Canada. This impending shift marks a significant development in the pharmaceutical landscape, promising greater accessibility and potentially lower costs for millions of patients. As reported by The New York Times, the introduction of generic versions could reshape treatment options and healthcare dynamics in these populous countries, where managing chronic conditions like diabetes remains a major public health priority.
Ozempic’s Patent Expiry Opens Door for Affordable Diabetes Treatment in Major Markets
With the expiration of Ozempic’s patent in key markets such as India, China, and Canada, healthcare providers and patients alike are anticipating a significant reduction in the cost of this groundbreaking diabetes medication. Pharmaceutical companies are now free to produce generic versions, which is expected to increase accessibility and affordability for millions living with type 2 diabetes. This shift promises to alleviate the financial strain on healthcare systems that have long struggled with the high price tag associated with innovative treatments like Ozempic.
Experts project the following impacts:
- Increased competition among generic manufacturers leading to price drops of up to 70%
- Greater availability in rural and underserved regions where diabetes management options are currently…
—-
Author : Ethan Riley
Publish date : 2026-03-20 15:10:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8